Salvia Bioelectronics
Clinical trials sponsored by Salvia Bioelectronics, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device zaps migraines away in Drug-Resistant patients Results expected Apr 2027 (estimated)
- Electric pulses to the head: new device aims to stop cluster headaches Results expected May 2027 (estimated)
-
Tiny trial hopes to zap migraines away with implanted nerve device
Symptom relief OngoingThis early study tests a new device called PRIMUS that stimulates nerves in the head and face to treat chronic migraine. Only 7 people with hard-to-treat migraines are taking part. The main goal is to see if the device is safe, not yet if it works.
Sponsor: Salvia BioElectronics • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Electric zaps to the head may ease cluster headaches
Symptom relief OngoingThis early study tests the safety of a new device called PRIMUS that uses mild electrical pulses on nerves in the forehead and back of the head to treat chronic cluster headache. Five people with frequent, hard-to-treat attacks will be enrolled. The goal is to see if the device i…
Sponsor: Salvia BioElectronics • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC